MOS
ANIK icon

MGO One Seven’s Anika Therapeutics ANIK Stock Holding History

MGO One Seven’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$3K Sell
55
-2,918
-98% -$165K ﹤0.01% 1420
2017
Q4 		$160K Buy
+2,973
New +$165K 0.07% 316

Other funds holding ANIK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.57B AUM 19.49% 1-Year Est. Return

MGO One Seven's ANIK Position: Q1 2018 in Review

MGO One Seven reduced its Anika Therapeutics (ANIK) stake by 98% in Q1 2018, selling an estimated $165K and leaving 55 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #1420.

MGO One Seven first reported a position in ANIK in Q4 2017 and has held it in 2 quarters since. The position peaked at $160K in Q4 2017. 170 funds tracked by Wall St. Rank hold ANIK as of Q1 2018.

  • MGO One Seven held 55 shares of Anika Therapeutics worth $3K as of Q1 2018.
  • MGO One Seven sold 2,918 Anika Therapeutics shares in Q1 2018, an estimated $165K.
  • Anika Therapeutics made up ﹤0.01% of MGO One Seven's portfolio in Q1 2018, its #1420 holding.
  • MGO One Seven first reported a position in Anika Therapeutics in Q4 2017 and has held it in 2 quarters since.
  • MGO One Seven's Anika Therapeutics position peaked at $160K in Q4 2017.
  • 170 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2018.

Based on MGO One Seven's 13F filing for Q1 2018, filed 15 May 2018.